title: Von Willebrand factor and angiogenesis: basic and applied issues.
abstract: The recent discovery that von Willebrand factor (VWF) regulates blood vessel formation has opened a novel perspective on the function of this complex protein. VWF was discovered as a key component of hemostasis, capturing platelets at sites of endothelial damage and synthesized in megakaryocytes and endothelial cells (EC). In recent years, novel functions and binding partners have been identified for VWF. The finding that loss of VWF in EC results in enhanced, possibly dysfunctional, angiogenesis is consistent with the clinical observations that in some patients with von Willebrand disease (VWD), vascular malformations can cause severe gastrointestinal (GI) bleeding. In vitro and in vivo studies indicate that VWF can regulate angiogenesis through multiple pathways, both intracellular and extracellular, although their relative importance is still unclear. Investigation of these pathways has been greatly facilitated by the ability to isolate EC from progenitors circulating in the peripheral blood of normal controls and patients with VWD. In the next few years, these will yield further evidence on the molecular pathways controlled by VWF and shed light on this novel and fascinating area of vascular biology. In this article, we will review the evidence supporting a role for VWF in blood vessel formation, the link between VWF dysfunction and vascular malformations causing GI bleeding and how they may be causally related. Finally, we will discuss how these findings point to novel therapeutic approaches to bleeding refractory to VWF replacement therapy in VWD.
authors: National Heart and Lung Institute, Imperial College, London, UK.
authors: A M
authors: AM
authors: Randi
authors: Department of Haematology, Imperial College, London, UK.
authors: M A
authors: MA
authors: Laffan
mesh_terms: D016888:Angiodysplasia / Q000378:metabolism; D000818:Animals; D001777:Blood Coagulation; D001792:Blood Platelets / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism; D006471:Gastrointestinal Hemorrhage / Q000097:blood; D006023:Glycoproteins / Q000378:metabolism; D006470:Hemorrhage; D006487:Hemostasis; D006801:Humans; D008533:Megakaryocytes / Q000378:metabolism; D051379:Mice; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D015398:Signal Transduction; D013234:Stem Cells / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism; D014842:von Willebrand Diseases / Q000378:metabolism; D014841:von Willebrand Factor / Q000378:metabolism*
chemical_list: D006023:Glycoproteins; D014841:von Willebrand Factor; D040301:Vascular Endothelial Growth Factor Receptor-2
keywords: VEGF receptor-2; angiodysplasia; angiopoietin-2; endothelial cells; hemostasis